An alarm issue was reported with the adc device in use with sama53-13 with android operating system version unknown.The low and high glucose alarms did not sound, and customer was not alerted of changes in glucose level.As a result, customer was not alerted of changes in glucose level and experienced a loss of consciousness and was unable to self-treat.The customer had contact with paramedics who administered anti-sickness medicine; however, no other treatment was reported.There was no report of death or permanent impairment associated with this event.
|
Repeated attempts by adc to retrieve the product were unsuccessful and/or the customer discarded the product.The most probable root causes associated with this failure mode are software/data corruption, or misuse.However, mitigations are in place to reduce and prevent such issues.All vital functions are monitored by the system and, when necessary, function is suspended to safeguard against inaccurate results.Labeling is provided to instruct the user on the intended use of all vital parts of the system to minimize misuse.All complaints and complaint trends are investigated to determine if there is a product defect/ deficiency.If a product defect/ deficiency is identified, a risk evaluation is completed and compared to the risk management report, to ensure the risk profile has not changed.Additionally, as a part of abbott¿s post-market surveillance process, all risk evaluations with associated complaint data are reviewed annually to determine if the risk profiles have changed as compared to the product risk management reports.These monitoring processes ensure that all product risk profiles remain acceptable and have a positive benefit/ risk ratio.At this time product has not yet been returned.An extended investigation has been performed for the reported complaint and it has been determined that there was no indication that the product did not meet specification.The dhrs (device history review) for the libre sensor and libre sensor kits were reviewed and the dhrs showed the libre sensor and libre sensor kits passed all tests prior to release.Smartphone compatibility with the use of freestyle librelink app and the samsung galaxy a33 device has not been tested at the time of the investigation.The compatibility guide states that abbott diabetes care has not assessed compatibility on phone/operating systems other than those listed.Abbott diabetes care product quality engineering (pqe) investigated the freestyle librelink complaint and determined that there were no issues with the librelink application that would have led to the complaint.The user reported signal loss.Attempted to replicate the user¿s complaint using application samsung galaxy s20 fe 5g (android 13; 2.10.1.10406) and was able to successfully start a libre 2 sensor, receive glucose readings and alarm notifications in the application.The user complaint could not be replicated.If the product is returned, a physical investigation will be performed, and a follow-up report submitted.All pertinent information available to abbott diabetes care has been submitted.
|
An alarm issue was reported with the adc device in use with sama53-13 with android operating system version unknown.The low and high glucose alarms did not sound, and customer was not alerted of changes in glucose level.As a result, customer was not alerted of changes in glucose level and experienced a loss of consciousness and was unable to self-treat.The customer had contact with paramedics who administered anti-sickness medicine; however, no other treatment was reported.There was no report of death or permanent impairment associated with this event.
|